Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use

@article{Lhermite2017CustomcompoundedBH,
  title={Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use},
  author={Marc L'hermite},
  journal={Climacteric},
  year={2017},
  volume={20},
  pages={205 - 211}
}
Abstract Wide rejection of conventional hormone therapy (HT) after the initial publication of the Women's Health Initiative (WHI) led to unjustified use of custom-compounded bioidentical hormones. In the USA, it became an unregulated drug manufacturer industry in disguise, without proper control and making false claims and misleading advertisements. Manufacturing quality is not ensured. Unspecific harm from compounding has occurred on a large scale, such as deaths from infected products and end… Expand
Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal
  • M. L'hermite
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2017
TLDR
MHT continuously combining oral micronized progesterone with transdermal estradiol can presently be considered as the optimal MHT, which is not only safer than custom-compounded bioidentical hormones but also than oral conventional MHT and has the best breast profile. Expand
The dangers of compounded bioidentical hormone replacement therapy.
  • L. Newson, J. Rymer
  • Medicine
  • The British journal of general practice : the journal of the Royal College of General Practitioners
  • 2019
TLDR
The subsequent sub-analysis of this study revealed reassuring and positive results to support the use of HRT, especially in younger women. Expand
Making choices at menopause.
TLDR
The aim of this article is to review the key components of the assessment of women who are perimenopausal or menopausal, and to discuss the benefits and risks of hormonal and non-hormonal treatments, thereby assisting clinicians to appropriately manage these women. Expand
Menopause Symptom Management in the United Kingdom.
  • D. Holloway
  • Medicine
  • The Nursing clinics of North America
  • 2018
TLDR
Menopause is a complex time in a woman's life, and this article covers the main presenting complaints and treatments, from lifestyle to hormone replacement therapy, by drawing on guidelines from national bodies. Expand
Red wine polyphenols modulate bone loss in the ovariectomized rat model of postmenopausal osteoporosis
TLDR
Dietary intake of RWPs for 6 months significantly prevented trabecular bone loss and improved bone strength in estrogen-deficient ovariectomized rats. Expand
News and views.

References

SHOWING 1-10 OF 83 REFERENCES
Risks and effectiveness of compounded bioidentical hormone therapy: a case series.
TLDR
Due to the lack of sufficient data to support the efficacy or safety of BHT, the use of United States Food and Drug Administration-approved regimens in the management of menopausal symptoms is recommended. Expand
Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
TLDR
While all types of hormone replacement therapies are safe and effective and confer significant benefits in the long-term when initiated in young postmenopausal women, in specific clinical settings the choice of the transdermal route of administration of estrogens and the use of natural progesterone might offer significant benefits and added safety. Expand
Risks and benefits of hormone therapy: has medical dogma now been overturned?
TLDR
Over-interpretation and misrepresentation of the WHI findings have damaged the health and well-being of menopausal women by convincing them and their health professionals that the risks of HT outweigh the benefits. Expand
HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT
  • M. L'hermite
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2013
TLDR
Natural, ‘body-identical’ progesterone appears to be the optimal progestogen in terms of cardiovascular effects, blood pressure, VTE, probably stroke and even breast cancer (contrary to synthetic progestogens and particularly MPA, which appear to be mitogenic on breast cells, in synergism with estrogen). Expand
Bioidentical hormones: what is all the hype about?
  • N. Panay, A. Fenton
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2010
TLDR
The possibility that different outcomes might be achieved, not only by varying the dose and age of initiation, but by the use of bioidentical hormones is explored. Expand
Bioidentical compounded hormones: a pharmacokinetic evaluation in a randomized clinical trial.
TLDR
This pharmacokinetic trial showed that the currently used doses of compounded hormones yield lower levels of estrogen compared to the standard-dose estradiol patch, and further studies are needed to find comparable doses. Expand
The Woman's Health Initiative and one of many unintended consequences.
TLDR
The article demonstrates that the obstetrician/gynecologist is particularly susceptible to personal and patient pressures to prescribe compounded hormonal therapies, and suggests the last of these three types of unexpected results, the perverse result. Expand
Bioidentical hormones for women with vasomotor symptoms.
TLDR
The effectiveness and safety of bioidentical hormone therapy compared to placebo or non-bioidentical hormones for the relief of vasomotor symptoms was determined and the overall quality of the evidence was evaluated. Expand
Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women
TLDR
The data suggest that many women are unaware that compounded hormones have not been evaluated or approved by the FDA, and providers have an educational opportunity to ensure that women considering hormone therapy understand the risks and benefits of inadequately regulated CHT. Expand
Low-potency oestrogen and risk of endometrial cancer: a case-control study
TLDR
Oral, but not vaginal, treatment with low-potency oestrogen formulations increases the relative risk of endometrial neoplasia, and addition of a progestagen should be considered. Expand
...
1
2
3
4
5
...